The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s joint pain injections market report forecasts the joint pain injections market size to grow to $7.13 Billion by 2027, with a CAGR (compound annual growth rate) of more than 8%.

Learn More On The Joint Pain Injections Market Report 2023 – https://www.thebusinessresearchcompany.com/report/joint-pain-injections-global-market-report

Joint Pain Injections Market Size Forecast
The global joint pain injections market is expected to grow from $4.66 billion in 2022 to $5.13 billion in 2023 at a compound annual growth rate (CAGR) of 10.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The joint pain injections market size is expected to grow to $7.13 billion in 2027 at a CAGR of 8.6%.

North America held the largest joint pain injections market share.

Key Joint Pain Injections Market Driver ­– Rise In The Prevalence Of Arthritis And Musculoskeletal Disorders
For instance, in February 2021, according to the report published by WHO, approximately 1.71 billion people in the world are affected by musculoskeletal conditions and the number of people with musculoskeletal disorders is continuously growing due to population growth and aging. Similarly, in 2021, according to the report by Global RA Network, arthritis affects about 350 million people worldwide and increasing rapidly. Therefore, the rising prevalence of arthritis and musculoskeletal disorder drives the joint pain injections market.

Request for A Sample Of The Global Joint Pain Injections Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6482&type=smp

Key Joint Pain Injections Market Trend – New Product Development
Major companies operating in the join pain injections sector are focused on new product innovations to meet consumer demand and strengthen their position. In September 2021, Contura International Ltd., a UK-based manufacturer of innovative therapeutic hydrogels, launched Arthrosamid. Arthrosamid is an innovative hydrogel injection for knee osteoarthritis that uses non-biodegradable hydrogel technology, offers an alternative to existing treatments, satisfies a clinical need for a potent, long-lasting, secure, and minimally intrusive method of treating knee osteoarthritis pain (OA).

Joint Pain Injections Market Segment
1) By Type Of Injection: Steroid Joint Injection, Hyaluronic Acid Injections, Platelet-Rich Plasma (PRP) Injections, Placental Tissue Matrix (PTM) Injections, Other Type Of InjectionS
2) By Joint Type: Hip Joint, Knee And Ankle, Shoulder And Elbow, Facet Joints Of The Spine, Other Joint Types
3) By Distribution channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Joint Pain Injections Market Major Players and Strategies
Major players in the joint pain injections market are Seikagaku Corporation, Flexion Therapeutics Inc., Zimmer Biomet, Sanofi, Anika Therapeutics Inc., Bioventus Inc., Ferring B.V., Chugai Pharmaceutical Co, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Wright Medical Group N.V, Pfizer Inc., OrthogenRx Inc., Fidia Farmaceutici s.p.a and Allergan PLC.

In October 2021, Pacira BioSciences, a US-based company specializing in non-opioid pain management has acquired Flexion Therapeutics for an amount of $630 Million. The acquisition aims to strengthens grant patients access to Zilretta (triamcinolone acetonide extended-release injectable suspension), the latter’s principal product, a non-opioid injection for pain treatment, and the only injection approved by FDA for intra-articular therapy for patients confronting osteoarthritisv (OA)-related knee pain. Pacira will also have access to two of Flexion’s medication candidates, FX201 and FX301, as a result of the acquisition. Flexion Therapeutics is a US-based company dedicated to developing novel, local therapies for the treatment of musculoskeletal disorders.

The Joint Pain Injections Global Market Report 2023 covers regional data on joint pain injections market size, joint pain injections market trends and drivers, opportunities, strategies, and joint pain injections market competitor analysis. The countries covered in the joint pain injections market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Joint pain injections reduce inflammation and discomfort and are typically injected directly into the joint for pain relief. Joint pain is very frequent among the elderly or as a result of pre-existing medical problems or disorders. It can happen as a result of musculoskeletal illnesses such as arthritis, which causes pain and inflammation. The joint pain injections are used to relieve joint pain and inflammation quickly through non-surgical treatments.

View More Reports Related To The Joint Pain Injections Market –
Joint Reconstruction Devices And Equipment Global Market Report 2023
Self-Injections Global Market Report 2023
Injection Molding Polyamide 6 Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: